Finder is committed to editorial independence. While we receive compensation when you click links to partners, they do not influence our content.

How to buy Covetrus (CVET) stocks in Canada

Learn how to easily invest in Covetrus stocks.

Covetrus Inc
+ $0.86 ( + 5.13%)

Covetrus is a health information services business based in the US. Covetrus stocks (CVET.US) are listed on the NASDAQ and all prices are listed in US Dollars. Its last market close was $25.52 – an increase of 1.7% over the previous week. Covetrus employs 5,275 staff and has a trailing 12-month revenue of around $4.6 billion.

How to buy shares in Covetrus

  1. Compare share trading platforms. Use our comparison table to help you find a platform that fits you.
  2. Open your brokerage account. Complete an application with your details.
  3. Confirm your payment details. Fund your account.
  4. Research the stock. Find the stock by name or ticker symbol – CVET – and research it before deciding if it's a good investment for you.
  5. Purchase now or later. Buy your desired number of shares with a market order or use a limit order to delay your purchase until the stock reaches a desired price.
  6. Check in on your investment. Optimize your portfolio by tracking your stock.

Covetrus stock price (NASDAQ:CVET)

Use our graph to track the performance of CVET stocks over time.

Covetrus shares at a glance

Information last updated 2022-01-17.
Latest market close$16.78
52-week range$15.80 - $40.78
50-day moving average $18.32
200-day moving average $22.92
Wall St. target price$26.00
PE ratio N/A
Dividend yield N/A (0%)
Earnings per share (TTM) $-0.41

Compare online stock trading platforms

Note: The dollar amounts in the table below are in Canadian dollars.

Name Product Finder Rating Stock Trading Fee Account Fee Available Asset Types Offer
Wealthsimple Trade
Finder Rating:
3.9 / 5
Stocks, ETFs
Get 2 free stocks when you deposit and trade $150.
Scotia iTRADE
Finder Rating:
3.8 / 5
$4.99 - $9.99
Bonds, Options, Mutual Funds, ETFs, GICs, International Equities
Interactive Brokers
Finder Rating:
4.1 / 5
Min. $1.00, Max. 0.5%
Stocks, Bonds, Options, ETFs, Currencies, Futures
CIBC Investor's Edge
Finder Rating:
4 / 5
$4.95 - $6.95
$0 if conditions met, otherwise $100/year
Stocks, Bonds, Options, Mutual Funds, ETFs
Get up to $2,000 cash back. Conditions apply. Offer ends March 1, 2022.
Finder Rating:
4.2 / 5
$4.95 - $9.95
Stocks, Bonds, Options, Mutual Funds, ETFs, GICs, International Equities, Precious Metals
Get $50 in free trades when you fund your account with a minimum of $1,000.
Qtrade Direct Investing
Finder Rating:
4.1 / 5
$6.95 - $8.75
$0 if conditions met, otherwise $25/quarter
Stocks, Bonds, Options, Mutual Funds, ETFs, GICs
Get a $50 bonus when you open a new RRSP, TFSA or RESP and start pre-authorized contributions of $200+/month. Valid until March 1, 2022.

Compare up to 4 providers

Online stock trading

Is it a good time to buy Covetrus stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

Covetrus price performance over time

Historical closes compared with the close of $16.78 from 2022-01-19

1 week (2022-01-14) 3.13%
1 month (2021-12-21) -8.21%
3 months (2021-10-21) -17.34%
6 months (2021-07-21) -33.52%
1 year (2021-01-21) -57.49%
2 years (2020-01-21) 11.35%
3 years (2019-01-17) N/A
5 years (2017-01-17) N/A

Is Covetrus under- or over-valued?

Valuing Covetrus stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of Covetrus's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.

Covetrus's PEG ratio

Covetrus's "price/earnings-to-growth ratio" can be calculated by dividing its P/E ratio by its growth – to give 1.3326. A low ratio can be interpreted as meaning the shares offer better value, while a higher ratio can be interpreted as meaning the shares offer worse value.

The PEG ratio provides a broader view than just the P/E ratio, as it gives more insight into Covetrus's future profitability. By accounting for growth, it could also help you if you're comparing the share prices of multiple high-growth companies.

Covetrus's EBITDA

Covetrus's EBITDA (earnings before interest, taxes, depreciation and amortisation) is $158 million.

The EBITDA is a measure of a Covetrus's overall financial performance and is widely used to measure a its profitability.

Covetrus financials

Revenue TTM $4.6 billion
Gross profit TTM $798 million
Return on assets TTM -0.22%
Return on equity TTM -3.55%
Profit margin -1.2%
Book value $10.91
Market capitalisation $2.2 billion

TTM: trailing 12 months

Covetrus share dividends

We're not expecting Covetrus to pay a dividend over the next 12 months.

Covetrus share price volatility

Over the last 12 months, Covetrus's shares have ranged in value from as little as $15.8 up to $40.775. A popular way to gauge a stock's volatility is its "beta".

CVET.US volatility(beta: 2.11)Avg. volatility(beta: 1.00)LowHigh

Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Covetrus's is 2.1112. This would suggest that Covetrus's shares are significantly more volatile than the average for this exchange and represent a higher risk.

Covetrus overview

Covetrus, Inc. , together with its subsidiaries, operates as an animal-health technology and services company. It engages in the sale of animal-health consumable products, including proprietary and Covetrus branded products, small equipment, laboratory products, large equipment, equipment repair services, branded and generic pharmaceuticals, vaccines, surgical products, diagnostic tests, infection-control products, parasiticides, and vitamins and supplements to wholesale and retail customers. The company also offers value-added solutions that include, inventory management and e-commerce, as well as continuing education services for practitioners. In addition, it provides practice management software systems for veterinary practitioners and animal-health clinics, client communication services, reminders, data backup services, and hardware sales and support services. Further, the company engages in the distribution of finished goods pharmacy and specialty pharmaceutical compounding products, as well as shipping, manufacturer incentives, service fees, and data integration and support services. It serves animal-health and veterinary practices, and clinics in the companion-animal and equine markets primarily in North America, Europe, and the Asia Pacific.

Frequently asked questions

Disclaimer: This information should not be interpreted as an endorsement of futures, stocks, ETFs, CFDs, options or any specific provider, service or offering. It should not be relied upon as investment advice or construed as providing recommendations of any kind. Futures, stocks, ETFs and options trading involves substantial risk of loss and therefore are not appropriate for all investors. Trading CFDs and forex on leverage comes with a higher risk of losing money rapidly. Past performance is not an indication of future results. Consider your own circumstances, and obtain your own advice, before making any trades.

More on investing

COVID testing stocks

COVID testing stocks

We’ve rounded up stats on some of the most popular COVID testing stocks, along with information on how they compare and how to invest.

Read more…


Review the benefits and risks of investing in these tech-focused ETFs.

Read more…
How to buy Canadian blue chip stocks

How to buy Canadian blue chip stocks

Edit partial cafst-category-stocks-excerpt in WP Admin

Read more…

More guides on Finder

Go to site